Zhiqun Shang

11PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersReaction engineering (excl. nuclear reactions)Basic pharmacologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 18, 2024
Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer.

Jianpeng Yu, Minghao Zhang, Taipeng Li

|Oct 02, 2023
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.

Xuanrong Chen, Yi Shao, Wanqing Wei

|Sep 09, 2023
YAP is required for prostate development, regeneration, and prostate stem cell function.

Hui Xie, Linpei Guo, Qianwang Ma

|Jul 31, 2023
Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC.

Boya Zhang, Mingpeng Zhang, Yanjie Yang

|May 03, 2023
CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling.

Jianpeng Yu, Tianyu Shen, Yang Li

|Apr 24, 2023
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.

Yang Li, Shimiao Zhu, Yutong Chen

Pageof 2

Frequent Collaborators

4 joint publications

Xuanrong Chen

2 joint publications

Tianyu Shen

2 joint publications

Zheng Zhang

1 joint publications

Yuanjie Niu